FOR IMMEDIATE RELEASE
May 8, 2012
Two-Faced Romney At It AgainRaising Campaign Dollars from Company that Manufactures Drug He Calls “Immoral” Adds to His Running List of Hypocrisies
Washington, D.C. – Nancy Keenan, president of NARAL Pro-Choice America, issued the following statement in response to former Gov. Mitt Romney’s latest display of inconsistency. According to a recent report by ThinkProgress, Romney’s campaign has made plans to accept campaign contributions from the makers of one form of emergency contraception (EC).
“Once again, Mitt Romney shows us that he cannot be trusted,” Keenan said. “As governor, Romney voted to deny rape survivors EC. But, now as a candidate for president, he will reap the benefits of a fundraiser hosted by the head of a pharmaceutical company that produces this important medication. If Romney truly finds EC objectionable, then how can he reasonably accept contributions from the very people who manufacture it?”
As governor of Massachusetts, Romney vetoed a measure that would have increased timely access to EC for sexual-assault survivors stating that, “I saw where the harsh logic of abortion can lead – to the view of innocent life as nothing more than research material or a commodity to be exploited.”[i][i]
Keenan continued, “Romney shows no integrity and doesn’t deserve to be elected to our nation’s highest office. His anti-choice stance trumps what’s best for women, but only when it doesn’t affect his campaign account’s bottom line. The American voters will not be fooled by someone who is so out of touch with our values and priorities.”
This latest fundraiser features a $50,000-a-plate dinner in support Romney’s campaign. Last month, two key anti-choice organizations— National Right to Life Committee and the Susan B. Anthony List (SBA)-- endorsed Mitt Romney. The SBA List has pledged to spend millions of dollars toward his campaign efforts.
For more information on Romney’s record on choice, please visit our website here.
[i][i] Mitt Romney, "Why I Vetoed Contraception Bill," Boston Globe, July 26, 2005.